Close

Tag: Coronavirus information (COVID-19)

China’s Experimental COVID-19 Vaccine Appears Safe In Early Trials Study

COVID-19 Vaccine: In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group's experimental shot showed no...

Second UK Covid-19 vaccine manufacturing site gets MHRA approval

The second of two GMP manufacturing sites for the UK’s specialist vaccines manufacturing equipment has been approved by the Medicines & Healthcare products Regulatory...

Zydus Cadila Covid vaccine likely to be ready by March 2021

Phase-2 trials of Zydus Cadila's indigenous vaccine ZyCoV-D is moving in the right direction and the data will be available by the end of...

Blue Dart strengthens temperature controlled logistics solution to fight against COVID-19

Blue Dart, India’s leading express logistics service provider and part of the Deutsche Post DHL Group (DPDHL) with its commitment to help improve the...

Recipharm signs agreement with Arcturus Therapeutics to support the manufacture of LUNAR -COV19 vaccine candidate

Recipharm, a leading contract development and manufacturing organisation (CDMO) has entered into an agreement with Arcturus Therapeutics, a leading U.S. based clinical-stage messenger RNA...

Eisai enters joint research pact with four research organizations in Japan for development of therapeutics for novel COVID-19

Eisai Co Ltd announced that it has entered into a joint research agreement with four research organizations (KAN Research Institute, National Center for Global...

Gilead takes over distribution of Covid-19 antiviral drug from federal government

The maker of the first antiviral drug to get authorization from regulators for Covid-19 anticipates meeting real-time demand for it around the world this...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read